Editorial: Patient-derived tumor models for drug development

被引：1
|
作者：
Sabaawy, Hatim E. [1 ]
Broggini, Massimo [2 ]
Gupta, Shiv K. [3 ]
机构：
[1] Univ Colorado Anschutz Med Campus, Dept Med, Div Med Oncol, Aurora, CO 80045 USA
[2] Ist Ric farmacolog Mario Negri IRCCS, Dept Oncol, Lab Mol Pharmacol, Milan, Italy
[3] Mayo Clin, Dept Radiat Oncol, Rochester, MN USA
来源：
FRONTIERS IN ONCOLOGY | 2023年 / 13卷
关键词：
patient-derived models of cancer; organoid; patient-derived xenograft (PDX); syngeneic graft; pre-clinical drug screen for cancer; immune checkpoint inhibitors; precision oncology; precision medicine; ORGANOIDS;
D O I：
10.3389/fonc.2023.1243534
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Patient-derived tumor xenograft models for melanoma drug discovery
    Harris, Antoneicka L.
    Joseph, Richard W.
    Copland, John A.
    [J]. EXPERT OPINION ON DRUG DISCOVERY, 2016, 11 (09) : 895 - 906
  • [2] PATIENT-DERIVED TUMOR XENOGRAFT MODELS: THE NEXT-GENERATION OF PRECLINICAL MODELS FOR ONCOLOGY DRUG DEVELOPMENT
    Eckhardt, S. G.
    Tan, A. C.
    Pitts, T.
    Leong, S.
    Arcaroli, J.
    Messersmith, W. A.
    Jimeno, A.
    Weekes, C. D.
    Tentler, J. J.
    [J]. ANNALS OF ONCOLOGY, 2012, 23 : 17 - 17
  • [3] Patient-derived tumour xenografts as models for oncology drug development
    Tentler, John J.
    Tan, Aik Choon
    Weekes, Colin D.
    Jimeno, Antonio
    Leong, Stephen
    Pitts, Todd M.
    Arcaroli, John J.
    Messersmith, Wells A.
    Eckhardt, S. Gail
    [J]. NATURE REVIEWS CLINICAL ONCOLOGY, 2012, 9 (06) : 338 - 350
  • [4] Patient-derived tumour xenografts as models for oncology drug development
    John J. Tentler
    Aik Choon Tan
    Colin D. Weekes
    Antonio Jimeno
    Stephen Leong
    Todd M. Pitts
    John J. Arcaroli
    Wells A. Messersmith
    S. Gail Eckhardt
    [J]. Nature Reviews Clinical Oncology, 2012, 9 : 338 - 350
  • [5] Patient-derived explants as tumor models
    Hubert, Christopher G.
    Rich, Jeremy N.
    [J]. CANCER CELL, 2022, 40 (04) : 348 - 350
  • [6] Perfused patient-derived tumor organoid models with autologous immune cells for preclinical drug development
    Millard, Melissa
    Dance, Natalie
    DesRochers, Teresa M.
    [J]. CANCER RESEARCH, 2023, 83 (07)
  • [7] Patient-derived Tumor Xenografts in Combination with High Content Imaging Platform as Models for Oncology Drug Development
    Praveen, K.
    Streiner, N.
    Ruiz-Lorroya, T.
    Garg, M.
    Murali, B.
    Hoffmaster, S.
    Vo, M.
    Broudy, T.
    Mirsaidi, C.
    [J]. EUROPEAN JOURNAL OF CANCER, 2012, 48 : 57 - 57
  • [8] Patient-derived tumour xenografts as models for breast cancer drug development
    Marangoni, Elisabetta
    Poupon, Marie-France
    [J]. CURRENT OPINION IN ONCOLOGY, 2014, 26 (06) : 556 - 561
  • [9] Tumor Evolution and Drug Response in Patient-Derived Organoid Models of Bladder Cancer
    Lee, Suk Hyung
    Hu, Wenhuo
    Matulay, Justin T.
    Silva, Mark V.
    Owczarek, Tomasz B.
    Kim, Kwanghee
    Chua, Chee Wai
    Barlow, LaMont J.
    Kandoth, Cyriac
    Williams, Alanna B.
    Bergren, Sarah K.
    Pietzak, Eugene J.
    Anderson, Christopher B.
    Benson, Mitchell C.
    Coleman, Jonathan A.
    Taylor, Barry S.
    Abate-Shen, Cory
    McKiernan, James M.
    Al-Ahmadie, Hikmat
    Solit, David B.
    Shen, Michael M.
    [J]. CELL, 2018, 173 (02) : 515 - +
  • [10] The promises and challenges of patient-derived tumor organoids in drug development and precision oncology
    Granat, Lauren M.
    Kambhampati, Ooha
    Klosek, Stephanie
    Niedzwecki, Brian
    Parsa, Kian
    Zhang, Dong
    [J]. ANIMAL MODELS AND EXPERIMENTAL MEDICINE, 2019, 2 (03) : 150 - 161
12345